1-8 of 8
Hartmut Goldschmidt, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Re-Transplantation for Patients with Relapsed Multiple Myeloma: A Single Center Experience with 200 Patients.

Kai Neben, MD, Leopold Sellner, MD, Christiane Heiss, Dipl.Stat, Axel Benner, Dipl.Stat., Marc S Raab, MD, Jens Hillengass, MD, Dirk Hose, MD, PhD, Nicola Lehners, MD, Gerlinde Egerer, MD, Anthony D Ho, MD, Hartmut Goldschmidt, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3086.
https://doi.org/10.1182/blood.V120.21.3086.3086
Published: 2012
Journal Articles

Relation Between Cereblon Expression and Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Thalidomide

Annemiek Broyl, MD, Rowan Kuiper, BSc, Mark van Duin, PhD, Bronno van der Holt, PhD, Laila el Jarari, MSc, Uta Bertsch, MD, Sonja Zweegman, MD, PhD, Arjan Buijs, PhD, Dirk Hose, MD, PhD, Henk Lokhorst, MD, PhD, Hartmut Goldschmidt, MD, PhD, Pieter Sonneveld, MD
Journal: Blood
Blood (2012) 120 (21): 3973.
https://doi.org/10.1182/blood.V120.21.3973.3973
Published: 2012
Journal Articles

Aurora-A Polymorphisms in Multiple Myeloma: Implications On Chromosomal Instability

Ludmila Weiz, Suzin Choi, PhD, Niels Weinhold, PhD, Kai Neben, MD, Anthony D Ho, MD, Hartmut Goldschmidt, MD, PhD, Kari Hemminki, PhD, Alwin Krämer, MD, Marc S Raab, MD
Journal: Blood
Blood (2012) 120 (21): 3982.
https://doi.org/10.1182/blood.V120.21.3982.3982
Published: 2012
Journal Articles

Targeting Mcl-1 for Multiple Myeloma (MM) Therapy: Drug-Induced Generation of Mcl-1 Fragment Mcl-1 128–350 Triggers MM Cell Death V ia c- Jun Upregulation

Fengjuan Fan, PhD, Giovanni Tonon, MD PhD, Martin Sattler, PhD, Alexander Schimming, Hartmut Goldschmidt, MD, PhD, Joseph Opferman, Ph.D, Kenneth C. Anderson, MD, Dirk Jaeger, MD, Klaus Podar, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3959.
https://doi.org/10.1182/blood.V120.21.3959.3959
Published: 2012
Journal Articles

Development of Bortezomib Induced Peripheral Neuropathy (BiPN) In Multiple Myeloma: Incidence and Molecular Characterization In Newly Diagnosed Patients Treated with Bortezomib

Annemiek Broyl, MD, Sophie Corthals, Joost L.M. Jongen, MD, PhD, Bronno van der Holt, PhD, Rowan Kuiper, Yvonne de Knegt, Laila el Jarari, Uta Bertsch, MD, PhD, Henk Lokhorst, MD, PhD, Brian GM Durie, MD, PhD, Hartmut Goldschmidt, MD, PhD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 304.
https://doi.org/10.1182/blood.V116.21.304.304
Published: 2010
Journal Articles

Gene Expression Profiles as Prognostic Factors in Patients with Multiple Myeloma Treated with Conventional Versus Novel Agents in Correlation with Outcome.

Annemiek Broyl, MD, Dirk Hose, MD, PhD, Yvonne de Knegt, Henk Lokhorst, MD, PhD, Hartmut Goldschmidt, MD, PhD, Mark van Duin, PhD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3173.
https://doi.org/10.1182/blood.V110.11.3173.3173
Published: 2007
Journal Articles

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Vaccination Strategies Determined by Microarray Analysis.

Maud Condomines, PharmD, Dirk Hose, MD, PhD, Thierry Reme, PhD, Michael Hundemer, John De Vos, MD, PhD, Marion Baudard, MD, PhD, Thomas Moehler, Veronique Pantesco, Jean-Francois Schved, MD, PhD, Jean-Francois Rossi, MD, PhD, Hartmut Goldschmidt, MD, PhD, Bernard Klein, PhD
Journal: Blood
Blood (2006) 108 (11): 3401.
https://doi.org/10.1182/blood.V108.11.3401.3401
Published: 2006
Journal Articles

The Human Plasma Cell Gene Expression Program.

John De Vos, MD, PhD, Dirk Hose, MD, PhD, Thierry Reme, MD, PhD, Hartmut Goldschmidt, MD, PhD, Jean-Francois Rossi, MD, PhD, Friedrich Cremer, MD, PhD, Bernard Klein, PhD
Journal: Blood
Blood (2004) 104 (11): 3242.
https://doi.org/10.1182/blood.V104.11.3242.3242
Published: 2004